Drug Manufacturers - Specialty & Generic Industry | Healthcare Sector | Mr. Zhi Gang Luo CEO | XSHE Exchange | CNE100001DP5 ISIN |
CN Country | 2,469 Employees | - Last Dividend | 30 Aug 2016 Last Split | 25 May 2012 IPO Date |
Yantai Dongcheng Pharmaceutical Group Co., Ltd., a conglomerate in the pharmaceutical industry, with its subsidiaries, delves into the production and distribution of biochemical Active Pharmaceutical Ingredients (APIs), finished dosage forms, nuclide drugs, and health-related products. These offerings cater to several therapeutic domains, including cardiovascular diseases, antitumor, urology, orthopedics, among others. Established in 1998, this enterprise has its roots and headquarters in Yantai, China, and has expanded its market footprint across approximately 40 countries and regions worldwide, covering Europe, the Americas, Asia Pacific, and other international territories.